Flourish Research Acquires Valley Clinical Trials
Flourish Research, backed by private equity firm NMS Capital, announced its acquisition of Valley Clinical Trials, based in the Los Angeles suburb of Northridge, California. The financial terms of the transaction were not disclosed. Valley Clinical Trials is a leading clinical research site with three locations in California that specialize in cardiology, metabolic and related therapeutic areas. Since its founding in 2010, Valley has rapidly grown into a leading multi-site clinical trials company serving a broad and diverse population of patients in Los Angeles County. Launched in 2021. Flourish Research is a clinical trial site network. The company has sites throughout... Read More »
Shore Capital-Backed SENTA Partners Acquires Advanced ENT and Allergy
Southern Ear Nose Throat & Allergy (SENTA) Partners, a portfolio company of private equity firm Shore Capital Partners, has announced a new partnership with Advanced ENT and Allergy, with locations in Kentucky and Indiana. Advanced ENT and Allergy is a leading ear, throat & nose (ENT) and allergy practice in the Southern United States, with nearly 170 employees across six locations. According to its website, there are 14 physicians on staff. Founded in 2019, SENTA Partners is an ENT and allergy management services organization with more than 930 employees, including 180 providers across 66 locations in seven states. This partnership further solidifies SENTA’s... Read More »
Ivy Rehab Expands in Illinois with PTSIR Deal
Ivy Rehab, a portfolio company of middle-market private equity firm Waud Capital Partners, has announced a partnership with Physical Therapy and Sports Injury Rehabilitation (PTSIR). Established in 1976, PTSIR is one of the nation’s oldest physical and occupational therapy practices based in the Greater Chicago area. Founded in 2003, Ivy Rehab is a network of outpatient physical, occupational and speech therapy and ABA clinics throughout the United States. The acquisition of PTSIR expands Ivy Rehab’s footprint in the Chicago MSA. Financial terms of the deal were not disclosed. According to data captured in the LevinPro HC database, this transaction... Read More »
New Harbor Capital Builds Out Clinical Research Site Platform With Acquisition
New Harbor Capital has acquired Monroe Biomedical Research to build out a more robust clinical research platform. Monroe Biomedical Research is a 6,300-square-foot clinical research facility in Monroe, near Charlotte, North Carolina. Monroe Biomedical conducts clinical research studies for asthma, COPD, diabetes, hypertension, heart failure, Alzheimer’s and COVID-19. New Harbor Capital invests in lower middle market, growth-oriented business services, healthcare and education companies. Since 2000, New Harbor has completed more than 230 investments. Crosstree Capital Partners acted as advisor to Monroe Biomedical and helped the target identify New Harbor Capital as... Read More »